Erenumab Side Effects
Medically reviewed by Drugs.com. Last updated on Oct 6, 2020.
For the Consumer
Applies to erenumab: subcutaneous solution
Side effects requiring immediate medical attention
Along with its needed effects, erenumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking erenumab:
Less common
Incidence not known
- Blurred vision
- cough
- dizziness
- fast heartbeat
- fever
- headache
- hives, itching, skin rash
- hoarseness
- irritation
- joint pain, stiffness, or swelling
- large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals
- nervousness
- pounding in the ears
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- redness of the skin
- slow or fast heartbeat
- tightness in the chest
- troubled breathing or swallowing
- unusual tiredness or weakness
Side effects not requiring immediate medical attention
Some side effects of erenumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
Less common
- Muscle cramp or spasm
For Healthcare Professionals
Applies to erenumab: subcutaneous solution
General
The more commonly reported adverse reactions have included injection site reactions and constipation.[Ref]
Hypersensitivity
Postmarketing reports: Hypersensitivity reactions including rash, angioedema, and anaphylaxis
Local
Common (1% to 10%): Injection site reactions
Frequency not reported: Injection site erythema, injection site pruritus, injection site pain
Injection site reactions included reports such as injection site pain and injection site erythema. Injection site reactions were reported in 6%, 5%, and 3% of patients receiving 70 mg/month, 140 mg/month, and placebo, respectively.
Gastrointestinal
Common (1% to 10%): Constipation
Musculoskeletal
Common (1% to 10%): Cramps, muscle spasms
Other
Common (1% to 10%): Fatigue
Dermatologic
Common (1% to 10%): Pruritus
References
1. "Product Information. Aimovig (erenumab)." Amgen USA, Thousand Oaks, CA.
Frequently asked questions
- Emgality vs Aimovig - how do they compare?
- How long does it take for Aimovig to start working?
- Ajovy vs Aimovig: What's the difference between them?
- What are the new drugs for the treatment and prevention of migraine?
- Does Aimovig cause weight gain or loss?
- Why does Aimovig cause constipation?
- What is the mechanism of action of Aimovig?
- Can you drink alcohol with Aimovig?
- Can Aimovig cause hair loss (alopecia)?
- How long does Aimovig last in your system?
- What is the cost of the migraine drug Ajovy?
- How does Aimovig work to prevent migraine?
- How do you use the Aimovig autoinjector?
- What type of drug is Ajovy?
- How do you inject Aimovig?
More about erenumab
- During Pregnancy or Breastfeeding
- Dosage Information
- Support Group
- En Español
- 505 Reviews
- Drug class: CGRP inhibitors
Consumer resources
- Other brands
- Aimovig
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.